Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ. Brooks Jackson, Francis Mmiro, Corey Duefield et al.|The Lancet|2003Cited by 525
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trialHoosen Coovadia, Yvonne Maldonado, Elizabeth R. Brown et al.|The Lancet|2011Cited by 142
Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 MonthsAvinash K. Shetty, Mary T. Bassett, Hoosen Coovadia et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2003Cited by 64
Intrapartum and Neonatal Single-Dose Nevirapine Compared With Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-Month Follow Up of the HIVNET 012 Randomized TrialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|Obstetrical & Gynecological Survey|2004Cited by 50
Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding InfantsJessica M. Fogel, Susan H. Eshleman, Anthony Mwatha et al.|The Pediatric Infectious Disease Journal|2012Cited by 43